Patent directory · USPTO A61K / A61P
Patents matching “LTD.”
1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9675588
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
granted -
US 9670194
Substituted aminopyrimidine compounds and methods of use
granted -
US 9662349
Dietary composition having mixed polysaccharides derived from lucid ganoderma, lycium barbarum and polygonatum sibiricum and method of its preparation
granted -
US 9663498
Aromatic heterocyclic compounds and their application in pharmaceuticals
granted -
US 9662322
Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status
granted -
US 9657007
Substituted aminopyrimidine compounds and methods of use
granted -
US 9655938
Compositions of polymeric myrcene
granted -
US 9636305
Antiemetic extended release solid dosage forms
granted -
US 9637519
Peptide for inducing mast cell-specific apoptosis and use thereof
granted -
US 9629385
Dietary composition containing cistanche deserticola polysaccharide with inhibitory effects on colon cancer
granted -
US 9625473
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted -
US 9624259
Compositions and methods for scaffold formation
granted -
US 9617596
Biomarkers predictive for clinical response for glatiramer acetate
granted -
US 9609883
Method for producing wheat glutamine peptide
granted -
US 9610331
Methods for hematopoietic precursor mobilization
granted -
US 9603907
Dry powder formulations of dNase I
granted -
US 9603806
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted -
US 9603906
Inhalable liquid formulations of DNase I
granted -
US 9598401
Substituted heteroaryl compounds and methods of use thereof
granted -
US 9598400
Substituted quinoline compounds and methods of use
granted -
US 9585878
Treatment of BDNF-related disorders using laquinimod
granted -
US 9574012
AGR2 blocking antibody and use thereof
granted -
US 9573953
Heteroaromatic compounds as PI3 kinase modulators and methods of use
granted -
US 9567300
Hexahydropentaleno derivatives, preparation method and use in medicine thereof
granted